Direvo Biotech AG and Pfizer Inc. Collaborate on Therapeutic Proteases
DIREVO Biotech AG today announced the signing of a collaboration agreement with Pfizer, Inc., New York, to develop therapeutic proteases for different targets as potential treatments for various diseases. Direvo will apply its protein-engineering capabilities to create novel proteases with engineered specificity for these targets.